SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-028943
Filing Date
2022-08-10
Accepted
2022-08-10 16:12:06
Documents
47
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q evok-10q_20220630.htm   iXBRL 10-Q 1213037
2 EX-3.1 evok-ex31_476.htm EX-3.1 12874
3 EX-31.1 evok-ex311_10.htm EX-31.1 9593
4 EX-31.2 evok-ex312_6.htm EX-31.2 9864
5 EX-32.1 evok-ex321_7.htm EX-32.1 6544
6 EX-32.2 evok-ex322_8.htm EX-32.2 6715
7 GRAPHIC ghx2sofxlltq000001.jpg GRAPHIC 336233
  Complete submission text file 0001564590-22-028943.txt   4717120

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA evok-20220630.xsd EX-101.SCH 33331
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE evok-20220630_cal.xml EX-101.CAL 22781
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE evok-20220630_def.xml EX-101.DEF 90530
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE evok-20220630_lab.xml EX-101.LAB 235439
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evok-20220630_pre.xml EX-101.PRE 173382
41 EXTRACTED XBRL INSTANCE DOCUMENT evok-10q_20220630_htm.xml XML 543982
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36075 | Film No.: 221151952
SIC: 2834 Pharmaceutical Preparations